IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 42 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,217,438 | -13.1% | 485,886 | +0.4% | 0.02% | -10.0% |
| Q2 2023 | $29,006,074 | +29.3% | 483,757 | +6.6% | 0.02% | +25.0% |
| Q1 2023 | $22,436,069 | -21.7% | 453,804 | -9.6% | 0.02% | -27.3% |
| Q4 2022 | $28,648,172 | +16.0% | 501,983 | -4.6% | 0.02% | +10.0% |
| Q3 2022 | $24,703,000 | +120.7% | 526,252 | +75.4% | 0.02% | +150.0% |
| Q2 2022 | $11,191,000 | +58.9% | 299,950 | +27.3% | 0.01% | +100.0% |
| Q1 2022 | $7,043,000 | -12.3% | 235,545 | +0.5% | 0.00% | -20.0% |
| Q4 2021 | $8,027,000 | +17.1% | 234,439 | +26.8% | 0.01% | +25.0% |
| Q3 2021 | $6,855,000 | -0.9% | 184,925 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $6,916,000 | +31.5% | 177,105 | +43.3% | 0.00% | 0.0% |
| Q1 2021 | $5,260,000 | – | 123,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |